Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter [0.03%]
银屑病严重程度与非酒精性脂肪肝程度的相关性：控制衰减参数测量结果
Nico Gandha,Larisa Paramitha Wibawa,Tjut Nurul Alam Jacoeb et al.
Nico Gandha et al.
Background: A growing body of evidence links psoriasis to several metabolic disorders, but the causal relationship between psoriasis and nonalcoholic fatty liver disease (NAFLD) remains understudied. ...
The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy [0.03%]
生物制剂治疗银屑病患者的日常实践中合并的和新发的银屑病关节炎：基于队列的研究
Marloes E van Muijen,Tamara W van Hal,Hans M M Groenewoud et al.
Marloes E van Muijen et al.
Background: Previously identified risk factors for psoriatic arthritis (PsA); nail dystrophy and scalp lesions are highly prevalent in patients with moderate-to-severe psoriasis. Therefore, these variables may not be usef...
The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East [0.03%]
非洲和中东地区治疗斑块型银屑病患者的临床指南的需求未得到满足
Martin Steinhoff,Alfred F Ammoury,Haytham Mohamed Ahmed et al.
Martin Steinhoff et al.
Purpose: Dermatologists practicing in African and Middle Eastern countries face numerous challenges when managing patients with plaque psoriasis, especially those with disease in a difficult-to-treat anatomic area or thos...
Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients [0.03%]
埃及银屑病患者中循环细胞-free DNA作为炎症标志物的作用
Haneya A A Anani,Amany M Tawfeik,Soheir S Maklad et al.
Haneya A A Anani et al.
Background: Cell lesion and apoptosis with release of cell-free DNA (CFD) in circulation are associated with chronic inflammation of psoriasis. Objective:...
Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate [0.03%]
富马酸二甲酯通过作用于MSK1、RSK1/2以及IKKα/β激酶调控银屑病外周血单个核细胞中NF-κB/p65活化：基于重度斑块型银屑病患者用药前后的临床研究
Borbala Gesser,Mads K Rasmussen,Lars Iversen
Borbala Gesser
Background: Dimethyl fumarate (DMF) has an inhibitory effect on the production of pro-inflammatory proteins from different cells which participate in the immune reaction in psoriatic skin. Most recently it was shown that ...
Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives [0.03%]
托法替尼治疗活动性银屑病关节炎：患者选择和展望
Karen Ly,Kristen M Beck,Mary P Smith et al.
Karen Ly et al.
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic...
Christina Fotiadou,Elizabeth Lazaridou
Christina Fotiadou
Uveitis, an inflammatory disorder of the mid-portion of the eye, is considered a relatively rare but very serious ocular complication of psoriasis. Data on the specific characteristics of uveitis in the background of psoriasis are extremely...
A narrative review of psoriasis and multiple sclerosis: links and risks [0.03%]
关于银屑病和多发性硬化的文献回顾：联系与风险因素
Annika S Silfvast-Kaiser,Katie B Homan,Bobbak Mansouri
Annika S Silfvast-Kaiser
The association of psoriasis (PsO) with other autoimmune and autoinflammatory diseases has long been a topic of interest. Although previous studies have attempted to clarify the specific relationship between PsO and multiple sclerosis (MS),...
Psoriasis and alcohol [0.03%]
酒和银屑病
Caroline Svanström,Sol-Britt Lonne-Rahm,Klas Nordlind
Caroline Svanström
Psoriasis is a chronic inflammatory skin disease that may be triggered or worsened by several factors, including alcohol. A higher than average alcohol consumption is common among individuals with psoriasis. Neurobiological signaling affect...
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum] [0.03%]
用于治疗中重度斑块型银屑病和银屑病关节炎的新兴治疗方案：评估Bimekizumab及其潜在疗效[勘误表]
Published Erratum
Psoriasis (Auckland, N.Z.). 2019 Aug 15:9:73-74. DOI:10.2147/PTT.S225339 2019